ADAMIS PHARMACEUTICALS CORP (ADMP) Stock Earnings & Estimates
NASDAQ:ADMP - US00547W3079 - Common Stock
0.7751 USD
+0.01 (+0.86%)
0.77 USD
-0.01 (-0.66%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2020 | 2021 | 2022 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 2.78M -87.43% | 2.21M -20.50% | 4.76M 115.38% | |
| EBITDA YoY % growth | -28.07M -7.59% | -30.63M -9.12% | -23.58M 23.02% | |
| EBIT YoY % growth | -31.68M -9.13% | -32.07M -1.23% | -25.06M 21.86% | |
| Operating Margin | -1,139.57% | -1,451.13% | -526.47% | |
| EPS YoY % growth | -0.62 -12.73% | -0.35 43.55% | N/A |
All data in USD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in USD
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2022 Q2Q % growth | -0.03 72.73% | % | ||
| Q2 2022 Q2Q % growth | -0.06 | -0.04 | -0.02 | -68.07% |
| Q1 2022 Q2Q % growth | -0.07 41.67% | -0.03 | -0.04 | -128.76% |
| Q4 2021 Q2Q % growth | -0.06 75.00% | -0.05 | -0.01 | -30.72% |
| Q3 2021 Q2Q % growth | -0.11 -10.00% | -0.04 | -0.07 | -169.61% |
| Q2 2021 Q2Q % growth | -0.06 53.85% | -0.06 | 0.00 | -6.95% |
| Q1 2021 Q2Q % growth | -0.12 20.00% | -0.06 | -0.06 | -96.08% |
| Q4 2020 Q2Q % growth | -0.24 -200.00% | -0.06 | -0.18 | -292.16% |
| Q3 2020 Q2Q % growth | -0.10 16.67% | -0.05 | -0.05 | -83.84% |
| Q2 2020 Q2Q % growth | -0.13 18.75% | -0.08 | -0.05 | -66.23% |
| Q1 2020 Q2Q % growth | -0.15 21.05% | -0.06 | -0.09 | -159.50% |
| Q4 2019 Q2Q % growth | -0.08 | -0.04 | -0.04 | -113.88% |
| Q3 2019 Q2Q % growth | -0.12 | -0.09 | -0.03 | -38.41% |
| Q2 2019 Q2Q % growth | -0.16 | -0.13 | -0.03 | -20.66% |
| Q1 2019 Q2Q % growth | -0.19 | -0.17 | -0.02 | -12.89% |
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q2 2023 Q2Q % growth | 10K 120.00% | % | ||
| Q1 2023 Q2Q % growth | 1.45M 26.09% | % | ||
| Q4 2022 Q2Q % growth | 2.15M 276.23% | % | ||
| Q3 2022 Q2Q % growth | 1.51M 98.68% | % | ||
| Q2 2022 Q2Q % growth | -50K -103.91% | 1.038M | -1.088M | -104.82% |
| Q1 2022 Q2Q % growth | 1.15M -17.27% | 3.831M | -2.681M | -69.98% |
| Q4 2021 Q2Q % growth | -1.22M -279.41% | 2.874M | -4.094M | -142.45% |
| Q3 2021 Q2Q % growth | 760K -12.64% | 1.42M | -659.84K | -46.47% |
| Q2 2021 Q2Q % growth | 1.28M 137.32% | 3.154M | -1.874M | -59.42% |
| Q1 2021 Q2Q % growth | 1.39M -70.17% | 3.535M | -2.145M | -60.68% |
| Q4 2020 Q2Q % growth | 680K -87.73% | 5.821M | -5.141M | -88.32% |
| Q3 2020 Q2Q % growth | 870K -85.25% | 7.118M | -6.248M | -87.78% |
| Q2 2020 Q2Q % growth | -3.43M -159.55% | 5.372M | -8.802M | -163.85% |
| Q1 2020 Q2Q % growth | 4.66M -5.09% | 6.524M | -1.864M | -28.57% |
| Q4 2019 Q2Q % growth | 5.54M | 7.14M | -1.6M | -22.41% |
| Q3 2019 Q2Q % growth | 5.9M | 6.503M | -603K | -9.27% |
| Q2 2019 Q2Q % growth | 5.76M | 5.957M | -197K | -3.31% |
| Q1 2019 Q2Q % growth | 4.91M | 5.907M | -997K | -16.88% |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |